PUT/NOVO-NORDISK B/400/2/21.06.24 Stock

Warrant

DE000GP5QRQ9

Market Closed - BOERSE MUENCHEN 02:25:30 2024-05-31 pm EDT
0.024 EUR -25.00% Intraday chart for PUT/NOVO-NORDISK B/400/2/21.06.24
1 month-61.29%
3 months-89.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 0.024 -25.00%
24-05-30 0.032 -13.51%
24-05-29 0.037 +2.78%
24-05-28 0.036 -32.08%
24-05-27 0.053 -5.36%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 02:25 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
Issuer Goldman Sachs
WKN GP5QRQ
ISINDE000GP5QRQ9
Date issued 2023-06-12
Strike 400 kr
Maturity 2024-06-21 (20 Days)
Parity 0.5 : 1
Emission price 2.94
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.21
Lowest since issue 0.003
Delta0x
Omega 0.000000
Premium0x
Gearing163.42x
Moneyness 0.4314
Difference Strike -527.3 kr
Difference Strike %-131.83%
Spread 3
Spread %99.34%
Intrinsic value 0.000000
Present value 1.524

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3 DKK
Average target price
917.2 DKK
Spread / Average Target
-1.09%
Consensus